Genomic and proteomic analysis of the inhibition of synthesis and secretion of aldosterone hormone induced by quinocetone in NCI-H295R cells

Toxicology. 2016 Mar 28:350-352:1-14. doi: 10.1016/j.tox.2016.03.005. Epub 2016 Apr 1.

Abstract

Quinoxaline 1,4-dioxides (QdNOs) are widely used as a kind of antibacterial growth promoter in animal husbandry. The adrenal cortex was found to be one of the main toxic targets of QdNOs, accompanied by a decreased aldosterone level. However, the way in which QdNOs decrease production of the hormone aldosterone is far from clear. To illustrate the mechanism by which QdNOs damage the adrenal cortex and decrease aldosterone hormone levels, the QdNOs were screened to choose the drug with most toxic effects on aldosterone production, and then to reveal the mechanism between the gene and protein profiles in human adrenocortical cells (NCI-H295R cells). The results found that quinocetone (QCT) showed the highest adrenal toxic effect among QdNOs. After exposing H295R cells to 10 and 20μM QCT for 24h, compared with blank cells, the gene and protein expression profiles obtained were analyzed by microarray and MALDI TOF/TOF mass spectrometry, respectively. The results of microarray analysis suggested that ABCG1 and SREBF1, which were involved in the cholesterol biosynthetic and metabolic processes, and CYP17A1, NR4A2 and G6PD, which were related to aldosterone biosynthesis, were important molecular targets. It has been speculated that PKC and ERK pathways might be involved in the reduction of aldosterone production caused by QCT, through enhanced mRNA expression of CYP17A1. Additionally, JNK and p38MAPK signal transduction pathways might participate in apoptosis induced by QCT. Twenty-nine and 32 protein spots were successfully identified when cells were treated with 10 and 20μM QCT, respectively. These identified proteins mainly included material synthesis and energy metabolism-related proteins, transcription/translation processing-related proteins, signal transduction proteins, cytoskeletal proteins, molecular chaperones, proteins related to response to stress, and transport proteins. Further investigations suggested that oxidative stress caused by QCT was exacerbated through disruption of the Keap1/Nrf2/ARE anti-oxidative stress pathway. Taken together, the data demonstrated for the first time that the Keap1/Nrf2/ARE pathway plays a crucial role in adrenal toxicity, and that CYP17A1 was the key switch to reduce the aldosterone production induced by QCT. Furthermore, large numbers of genes and proteins and entry points for research in the inhibition of aldosterone synthesis induced by QCT were offered, which will provide new insight into the adrenal toxicity of QdNOs and help to provide a theoretical foundation for the formulation of safety controls for products obtained from animals and to design new QdNOs with less harmful effects.

Keywords: Adrenal; Aldosterone; Genomics; NCI-H295R cells; Proteomics; Quinocetone.

MeSH terms

  • Adrenal Cortex / drug effects*
  • Adrenal Cortex / pathology
  • Adrenal Cortex Neoplasms / metabolism*
  • Aldosterone / biosynthesis*
  • Aldosterone / metabolism
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Dose-Response Relationship, Drug
  • Gene Expression Regulation / drug effects
  • Genomics / methods
  • Humans
  • Mass Spectrometry / methods
  • Microarray Analysis
  • Oxidative Stress / drug effects*
  • Proteomics / methods
  • Quinoxalines / administration & dosage
  • Quinoxalines / toxicity*
  • Signal Transduction / drug effects
  • Steroid 17-alpha-Hydroxylase / genetics

Substances

  • Quinoxalines
  • quinocetone
  • Aldosterone
  • CYP17A1 protein, human
  • Steroid 17-alpha-Hydroxylase